Todd Michael Groendyke

Title: Todd Michael Groendyke: Innovator in Glutamate Receptor Potentiation

Introduction

Todd Michael Groendyke is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that enhance glutamate receptor activity. With a total of 4 patents to his name, Groendyke's work is paving the way for new therapeutic approaches.

Latest Patents

Groendyke's latest patents focus on potentiators of glutamate receptors. The first patent provides compounds of formula (I), along with pharmaceutical compositions and methods for their use. The second patent relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, aimed at treating migraines. This application also details processes for preparing the compound and intermediate compounds useful in the treatment.

Career Highlights

Todd Michael Groendyke is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to collaborate with other talented professionals in the field, contributing to innovative solutions in medicine.

Collaborations

Some of Groendyke's notable coworkers include Thomas Daniel Aicher and Guillermo S Cortez. Their combined expertise enhances the research and development efforts at Eli Lilly.

Conclusion

Todd Michael Groendyke is a distinguished inventor whose work on glutamate receptor potentiators is making a significant impact in the pharmaceutical industry. His contributions are essential for advancing treatment options for conditions such as migraines.